Health Care & Life Sciences » Biotechnology | Minerva Neurosciences Inc.

Minerva Neurosciences Inc.

Minerva Neurosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.38
Market Cap
$266.15 M
Shares Outstanding
39.03 M
Public Float
31.4 M

Profile

Address
1601 Trapelo Road
Waltham Massachusetts 02451
United States
Employees -
Website http://www.minervaneurosciences.com
Updated 07/08/2019
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.

Financials

View All
Created with Highcharts 5.0.14Minerva Neurosciences Inc.Net Income. Fiscal year is January-December. All values USD Thousands.3 2623 26256 90156 90127 08127 08131 04531 04531 52331 52350 17150 171201320142015201620172018010k20k30k40k50k60k

Rémy Luthringer
Executive Chairman & Chief Executive Officer
Jeryl L. Hilleman
Director